Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Q&A: EARLY TAVR co-author questions study | 'Fraudulent’ cardiologist linked to deaths | Medtronic diabetes spin-off gets a name

News You Need to Know Today
Q&A: EARLY TAVR co-author questions study | 'Fraudulent’ cardiologist linked to deaths | Medtronic diabetes spin-off gets a name
Monday, June 16, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Q&A: Cardiologist and EARLY TAVR co-author questions study’s execution

The EARLY TAVR clinical trial made a significant impact, paving the way for the FDA to approve multiple transcatheter heart valves for the treatment of asymptomatic patients. However, one cardiologist who participated in the trial has some serious concerns with how its findings were presented to the public. 

READ MORE >
Hemal Gada, MD, cardiologist
Share on Twitter Share on Facebook Share on Linkedin

Q&A: Cardiologist and EARLY TAVR co-author questions study’s execution

Share on Twitter Share on Facebook Share on Linkedin
Hemal Gada, MD, cardiologist
The EARLY TAVR clinical trial made a significant impact, paving the way for the FDA to approve multiple transcatheter heart valves for the treatment of asymptomatic patients. However, one cardiologist who participated in the trial has some serious concerns with how its findings were presented to the public. 
READ MORE >

‘Unqualified and fraudulent’ cardiologist linked to three patient deaths

The doctor is accused of using fake credentials for several months and performing approximately 50 procedures. This is the second time in recent months someone has been accused of impersonating a heart specialist and treating patients.

READ MORE >
doctor_patients.jpg
Share on Twitter Share on Facebook Share on Linkedin

‘Unqualified and fraudulent’ cardiologist linked to three patient deaths

Share on Twitter Share on Facebook Share on Linkedin
doctor_patients.jpg
The doctor is accused of using fake credentials for several months and performing approximately 50 procedures. This is the second time in recent months someone has been accused of impersonating a heart specialist and treating patients.
READ MORE >

FDA-cleared software increases throughput for flurpiridaz back-to-back rest-stress imaging

The new F-18 flurpiridaz radiotracer is expected to help drive cardiac PET growth, but it requires waiting between rest and stress scans. Software from MultiFunctional Imaging can help care teams combat that problem.

READ MORE >
Imagers reviewing flurpiridaz F-18 (Flyrcado) myocardial perfusion PET images. Image from GE Healthcare
Share on Twitter Share on Facebook Share on Linkedin

FDA-cleared software increases throughput for flurpiridaz back-to-back rest-stress imaging

Share on Twitter Share on Facebook Share on Linkedin
Imagers reviewing flurpiridaz F-18 (Flyrcado) myocardial perfusion PET images. Image from GE Healthcare
The new F-18 flurpiridaz radiotracer is expected to help drive cardiac PET growth, but it requires waiting between rest and stress scans. Software from MultiFunctional Imaging can help care teams combat that problem.
READ MORE >

Medtronic’s diabetes spin-off gets a name, kicking off ‘new and exciting chapter’

The new name will be familiar to anyone who knows the history of Medtronic's diabetes business.

READ MORE >
business launch
Share on Twitter Share on Facebook Share on Linkedin

Medtronic’s diabetes spin-off gets a name, kicking off ‘new and exciting chapter’

Share on Twitter Share on Facebook Share on Linkedin
business launch
The new name will be familiar to anyone who knows the history of Medtronic's diabetes business.
READ MORE >

Featured Articles

Cardiac imaging pioneer remembered for his joy and enthusiasm

Former American Society of Echocardiography president and well-known cardiac ultrasound pioneer Roberto Lang, MD, died at the age of 73. He helped develop 3D echo technology that is now used by care teams on a daily basis.

READ MORE >
Roberto Lang speaking at ASE23 on AI industry partnerships.
Share on Twitter Share on Facebook Share on Linkedin

Cardiac imaging pioneer remembered for his joy and enthusiasm

Share on Twitter Share on Facebook Share on Linkedin
Roberto Lang speaking at ASE23 on AI industry partnerships.
Former American Society of Echocardiography president and well-known cardiac ultrasound pioneer Roberto Lang, MD, died at the age of 73. He helped develop 3D echo technology that is now used by care teams on a daily basis.
READ MORE >

GE HealthCare recalls legacy cardiology information systems due to security risk

GE HealthCare has warned that the devices could potentially be accessed and manipulated by an outside party. The FDA has classified this as a Class II recall. 

READ MORE >
the words "FDA recall" on a board
Share on Twitter Share on Facebook Share on Linkedin

GE HealthCare recalls legacy cardiology information systems due to security risk

Share on Twitter Share on Facebook Share on Linkedin
the words "FDA recall" on a board
GE HealthCare has warned that the devices could potentially be accessed and manipulated by an outside party. The FDA has classified this as a Class II recall. 
READ MORE >

Smaller revenues, less growth: In US, tariffs may create headaches for $34.5B cardiovascular device market

“Without a more concrete and stable policy on these tariffs from the current American administration, it is likely that most manufacturers will be forced to continuously change their internal forecasts and production plans," one analyst said.

READ MORE >
money maze benjamin franklin reimbursement medicare
Share on Twitter Share on Facebook Share on Linkedin

Smaller revenues, less growth: In US, tariffs may create headaches for $34.5B cardiovascular device market

Share on Twitter Share on Facebook Share on Linkedin
money maze benjamin franklin reimbursement medicare
“Without a more concrete and stable policy on these tariffs from the current American administration, it is likely that most manufacturers will be forced to continuously change their internal forecasts and production plans," one analyst said.
READ MORE >

In Case You Missed It

The lack of diversity in cardiac surgery trials may be harmful to patients

Mario Gaudino, MD, PhD, told Cardiovascular Business there is a major need for more women and minorities in today's clinical trials.

READ MORE >
Mario Gaudino, MD, explains why cardiac surgery trials need more diversity to better inform treatment decisions for women and minorities.
Share on Twitter Share on Facebook Share on Linkedin

The lack of diversity in cardiac surgery trials may be harmful to patients

Share on Twitter Share on Facebook Share on Linkedin
Mario Gaudino, MD, explains why cardiac surgery trials need more diversity to better inform treatment decisions for women and minorities.
Mario Gaudino, MD, PhD, told Cardiovascular Business there is a major need for more women and minorities in today's clinical trials.
READ MORE >

Private equity's influence continues to rise in cardiology—what does that mean for patient care?

Rishi Wadhera, MD, MPP, MPhil, a cardiologist who also specializes in healthcare policy, spoke to Cardiovascular Business about the good, the bad and the unknown when it comes to private equity's role in cardiology.

READ MORE >
Rishi Wadhera, MD, MPP, MPhil, associate director of the Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, and an associate professor of health policy and management, Harvard School of Public Health, explains the impact of private equity ownership of hospitals and private practices.
Share on Twitter Share on Facebook Share on Linkedin

Private equity's influence continues to rise in cardiology—what does that mean for patient care?

Share on Twitter Share on Facebook Share on Linkedin
Rishi Wadhera, MD, MPP, MPhil, associate director of the Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, and an associate professor of health policy and management, Harvard School of Public Health, explains the impact of private equity ownership of hospitals and private practices.
Rishi Wadhera, MD, MPP, MPhil, a cardiologist who also specializes in healthcare policy, spoke to Cardiovascular Business about the good, the bad and the unknown when it comes to private equity's role in cardiology.
READ MORE >

SCAI celebrates legacies of pioneer pediatric cardiologists

Five veteran clinicians have been recognized for their lasting impact on the field of pediatric cardiology. 

READ MORE >
Compensation for U.S. cardiologists is up across the board, according to a recent survey published by MedAxiom, an American College of Cardiology company. The report identified similar trends for cardiovascular surgeons, highlighting the country’s high demand for all heart specialists in 2024 and beyond.
Share on Twitter Share on Facebook Share on Linkedin

SCAI celebrates legacies of pioneer pediatric cardiologists

Share on Twitter Share on Facebook Share on Linkedin
Compensation for U.S. cardiologists is up across the board, according to a recent survey published by MedAxiom, an American College of Cardiology company. The report identified similar trends for cardiovascular surgeons, highlighting the country’s high demand for all heart specialists in 2024 and beyond.
Five veteran clinicians have been recognized for their lasting impact on the field of pediatric cardiology. 
READ MORE >

In Other News

FDA issues recall of Philips interventional imaging system due to safety risks

A communication error within the system can reportedly cause loss of imaging functionality mid-procedure.

READ MORE >
Recall | Product recall
Share on Twitter Share on Facebook Share on Linkedin

FDA issues recall of Philips interventional imaging system due to safety risks

Share on Twitter Share on Facebook Share on Linkedin
Recall | Product recall
A communication error within the system can reportedly cause loss of imaging functionality mid-procedure.
READ MORE >

UnitedHealthcare caves to pressure, exempting some imaging services from cost-cutting program

The country’s largest insurer launched its Designated Diagnostic Provider program in 2022, steering beneficiaries to imaging centers that meet quality and efficiency requirements. 

READ MORE >
UnitedHealth Group - 2
Share on Twitter Share on Facebook Share on Linkedin

UnitedHealthcare caves to pressure, exempting some imaging services from cost-cutting program

Share on Twitter Share on Facebook Share on Linkedin
UnitedHealth Group - 2
The country’s largest insurer launched its Designated Diagnostic Provider program in 2022, steering beneficiaries to imaging centers that meet quality and efficiency requirements. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Cardiologist compensation keeps climbing | Investing in robotic tech | Doc agrees to pay $6.7M | Virtual nurses
ASNC speaks to policymakers | New IVL tech impresses | FDA clears high-pressure balloon catheter | RSNA names a new editor
Pacemakers recalled again | Johnson & Johnson makes a move | GLP-1 drugs & AFib | Strokes after PFA | New LAAO data
More recalls announced due to high-risk device | AATS helps surgeons manage a major complication | How guidelines impact care
Week in Review: TAVR or SAVR? | Key trends in cardiac CT | Fraud allegations lead to $6.7M settlement | CTO PCI
FDA clears intravascular imaging tech | Key trends in cardiac CT | Heartflow sues rival | Opportunistic screening
Vascular specialist agrees to pay $6.7M | Robotic heart surgery: Worth the cost? | E-cigarette concerns | Heart tech on display

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …4
    • Page 5
    • Page 6
    • Page 7
    • Current page 8
    • Page 9
    • Page 10
    • Page 11
    • Page 12 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup